News & Articles

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

Exclusive interviews, free downloads, the latest methods and much more to help support your immuno-oncology research

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

Discover the importance of high-throughput and robust methodologies for finding ‘needle-in-the-haystack’ therapeutic antibodies

Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected

Party during Neuroscience 2018 celebrates the importance of effective conversation between scientists and manufacturers

Discover how AFABILITY founder Dr. Alison Gray is enabling the transition from animal-derived to non-animal-derived antibodies

The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution

The platform can directly isolate IgG genes from B cells of immunized animals

Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients

The Leo Foundation-funded study for first time identifies Sbi as the molecule that induces rapid release of Interleukin-33